These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11867808)

  • 41. Hepatic MR imaging using ferumoxides: prospective evaluation with surgical and intraoperative sonographic confirmation in 25 cases.
    Raman SS; Lu DS; Chen SC; Sayre J; Eilber F; Economou J
    AJR Am J Roentgenol; 2001 Oct; 177(4):807-12. PubMed ID: 11566677
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liver-specific contrast media for magnetic resonance imaging and computed tomography scanning: importance of contrast media for tumor detection in an experimental liver tumor model.
    Leander P; Golman K
    Acad Radiol; 1996 Aug; 3 Suppl 2():S420-2. PubMed ID: 8796620
    [No Abstract]   [Full Text] [Related]  

  • 43. Detection of hepatic lesions in candidates for surgery: comparison of ferumoxides-enhanced MR imaging and dual-phase helical CT.
    Bluemke DA; Paulson EK; Choti MA; DeSena S; Clavien PA
    AJR Am J Roentgenol; 2000 Dec; 175(6):1653-8. PubMed ID: 11090399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function.
    Tanimoto A; Yuasa Y; Shinmoto H; Jinzaki M; Imai Y; Okuda S; Kuribayashi S
    Radiology; 2002 Mar; 222(3):661-6. PubMed ID: 11867782
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of malignant hepatic tumors: comparison of gadolinium-and ferumoxide-enhanced MR imaging.
    Matsuo M; Kanematsu M; Itoh K; Ito K; Maetani Y; Kondo H; Kako N; Matsunaga N; Hoshi H; Shiraishi J
    AJR Am J Roentgenol; 2001 Sep; 177(3):637-43. PubMed ID: 11517061
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gray-scale liver enhancement in VX2 tumor-bearing rabbits using BR14, a new ultrasonographic contrast agent.
    Schneider M; Broillet A; Bussat P; Giessinger N; Puginier J; Ventrone R; Yan F
    Invest Radiol; 1997 Jul; 32(7):410-7. PubMed ID: 9228607
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intracranial aneurysms: detection with gadolinium-enhanced dynamic three-dimensional MR angiography-initial results.
    Metens T; Rio F; Balériaux D; Roger T; David P; Rodesch G
    Radiology; 2000 Jul; 216(1):39-46. PubMed ID: 10887226
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography.
    Senéterre E; Taourel P; Bouvier Y; Pradel J; Van Beers B; Daures JP; Pringot J; Mathieu D; Bruel JM
    Radiology; 1996 Sep; 200(3):785-92. PubMed ID: 8756932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanism of hepatic parenchyma-specific contrast of microbubble-based contrast agent for ultrasonography: microscopic studies in rat liver.
    Watanabe R; Matsumura M; Munemasa T; Fujimaki M; Suematsu M
    Invest Radiol; 2007 Sep; 42(9):643-51. PubMed ID: 17700280
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of malignant biliary obstruction: efficacy of fast multiplanar spoiled gradient-recalled MR imaging vs spin-echo MR imaging, CT, and cholangiography.
    Low RN; Sigeti JS; Francis IR; Weinman D; Bower B; Shimakawa A; Foo TK
    AJR Am J Roentgenol; 1994 Feb; 162(2):315-23. PubMed ID: 8310918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contrast enhanced ultrasound in the detection of liver metastases: a prospective multi-centre dose testing study using a perfluorobutane microbubble contrast agent (NC100100).
    Correas JM; Low G; Needleman L; Robbin ML; Cosgrove D; Sidhu PS; Harvey CJ; Albrecht T; Jakobsen JA; Brabrand K; Jenett M; Bates J; Claudon M; Leen E
    Eur Radiol; 2011 Aug; 21(8):1739-46. PubMed ID: 21479856
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of malignant hepatic lesions before orthotopic liver transplantation: accuracy of ferumoxides-enhanced MR imaging.
    Mori K; Scheidler J; Helmberger T; Holzknecht N; Schauer R; Schirren CA; Bittmann I; Dugas M; Reiser M
    AJR Am J Roentgenol; 2002 Oct; 179(4):1045-51. PubMed ID: 12239063
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis.
    Ward J; Naik KS; Guthrie JA; Wilson D; Robinson PJ
    Radiology; 1999 Feb; 210(2):459-66. PubMed ID: 10207430
    [TBL] [Abstract][Full Text] [Related]  

  • 54. B-mode enhancement of the liver with microbubble contrast agent: a blinded study in rabbits with VX2 tumors.
    Girard MS; Kono Y; Sirlin CB; Baker KG; Deiranieh LH; Mattrey RF
    Acad Radiol; 2001 Aug; 8(8):734-40. PubMed ID: 11508752
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liver lesions: manganese-enhanced MR and dual-phase helical CT for preoperative detection and characterization comparison with receiver operating characteristic analysis.
    Braga HJ; Choti MA; Lee VS; Paulson EK; Siegelman ES; Bluemke DA
    Radiology; 2002 May; 223(2):525-31. PubMed ID: 11997563
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging.
    Lutz AM; Seemayer C; Corot C; Gay RE; Goepfert K; Michel BA; Marincek B; Gay S; Weishaupt D
    Radiology; 2004 Oct; 233(1):149-57. PubMed ID: 15333767
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-breath-hold fast spin-echo versus breath-hold fast spin-echo and spoiled gradient-recalled echo MR imaging in the detection of hepatic tumors: correlation with surgical findings.
    Soyer P; Gouhiri M; Rondeau Y; Spelle L; Mosnier H; Scherrer A
    AJR Am J Roentgenol; 1997 May; 168(5):1199-204. PubMed ID: 9129411
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number.
    Lim JH; Choi D; Cho SK; Kim SH; Lee WJ; Lim HK; Park CK; Paik SW; Kim YI
    Radiology; 2001 Sep; 220(3):669-76. PubMed ID: 11526265
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liver tumors in cirrhosis: experimental study with SPIO-enhanced MR imaging.
    Clement O; Frija G; Chambon C; Schouman-Clayes E; Mosnier JF; Poupon MF; Balkau B
    Radiology; 1991 Jul; 180(1):31-6. PubMed ID: 2052718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging.
    Lee JM; Kim CS; Youk JH; Lee MS
    Korean J Radiol; 2003; 4(1):9-18. PubMed ID: 12679629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.